Biotech Values

[vinmantoo]

ENTA announces SARS-CoV-2_protease_inhibitor, EDP-235:

https://finance.yahoo.com/news/enanta-pharmaceuticals-announces-nomination-clinical-110000908.html

Thanks Dew. Good news for ENTA investors as now we at least get a rough timeline of the phase I safety trial to initiate. I have always felt antivirals would play a big role in defeating this pandemic. The rise of the delta variants really reinforces my view.

While the Covid-19 protease is likely an excellent target, I thought ENTA was trying to develop a multi-drug cocktail for Covid-19. Am I wrong or is another anti-viral designed to inhibit a different aspect of the viral life-cycle coming?